MEDIPAL HOLDINGS CORPORATION【JP:7459】Stock Price

Medipal Holdings is a corporate group that sells and provides services for pharmaceuticals, cosmetics and daily necessities, and veterinary pharmaceuticals. The group is composed of 34 subsidiaries and 18 affiliated companies, centered around the core company Medipal Holdings.

The company's business is divided into three main segments. First, in the pharmaceutical wholesale business, companies such as Mediseo Corporation and Evals Corporation handle prescription pharmaceuticals, medical devices, medical supplies, and clinical diagnostic reagents.

Second, in the cosmetics, daily necessities, and over-the-counter pharmaceutical wholesale business, PALTA Corporation provides cosmetics, daily necessities, and over-the-counter pharmaceuticals. This segment handles products closely related to everyday life.

Finally, in the veterinary pharmaceutical and food processing raw materials wholesale and related business, MP Agro Corporation handles veterinary pharmaceuticals and feed additives, while MP Gokyō Food & Chemical Corporation handles food ingredients, food additives, and chemical product materials.

Through these diverse operations, Medipal Holdings contributes to healthcare, daily life, and animal healthcare. Each segment leverages its expertise to provide products and services that meet customer needs.

Medipal Holdings pursues its growth strategy under the management philosophy of "contributing to people's health and social development through the creation of distribution value." The company aims to become a "health support orchestra" that expands, supports, and connects "healthcare, health, and beauty," thereby creating social and customer value.

The company has formulated the "2027 Medipal Medium-Term Vision Change the 卸 Forever～Continuous Innovation～" to pursue sustainable growth. Under this vision, the company is strengthening distribution infrastructure and expanding partnerships across its pharmaceutical, cosmetics and daily necessities, and animal health businesses.

Medipal Holdings has also established the sustainability policy "Connecting to the Future 'Vitality and Brilliance'" and is working to reduce environmental impact and promote diversity. The company aims to reduce greenhouse gas emissions and increase the proportion of women in management positions.

In its pharmaceutical wholesale business, the company is strengthening its role as a regional healthcare coordinator and deepening collaboration with medical institutions and pharmacies. It is also improving logistics efficiency and building safe, high-function logistics platforms.

In the cosmetics and daily necessities wholesale business, the company captures market changes through data utilization and introduces new products. In the animal health business, the company improves profitability through transactions with new manufacturers and focus on high-margin products.

Medipal Holdings has established five growth strategies: overseas expansion, utilization of digital technology, and construction of sustainable distribution. Through these initiatives, the company promotes value co-creation in regional healthcare and aims to enhance corporate value.